Company Number: 14383093

Analysis Date: 2025-07-29 14:24 UTC

1. Credit Opinion: APPROVE with conditions.
   DOT GLASSES INTERNATIONAL LTD is a micro-entity incorporated in late 2022, with its first financial statements filed for a 15-month period ending December 2023. The company shows a solid net asset position and positive working capital, indicating a good initial financial footing. However, as a newly established entity with only two employees and limited financial history, there is inherent uncertainty about its long-term sustainability and cash flow consistency. Approval is recommended with conditions including regular monitoring of financial performance and timely filing of future accounts and confirmation statements.

2. Financial Strength:
   The balance sheet as of 31 December 2023 shows total net assets of £128,231 with fixed assets of £45,504 and net current assets of £121,665. Current liabilities are low at £4,170, and there are no long-term liabilities reported. Accruals and deferred income amount to £37,392, and provisions for liabilities are minimal at £1,546. The company has a very small share capital of £2, indicating limited shareholder equity but the accumulated reserves and net assets suggest initial funding and retained earnings or capital injections. Overall, the financial structure appears healthy for a start-up with no debt burden, but the limited scale and short trading history require cautious interpretation.

3. Cash Flow Assessment:
   Current assets of £123,963 versus current liabilities of £4,170 imply strong liquidity and working capital management. No long-term borrowings or overdraft facilities are indicated, suggesting low financial risk from leverage. However, detailed cash flow statements are not provided, so cash generation from operations cannot be fully assessed. The low employee count (2) suggests limited payroll expenses, which helps conserve cash in early stages. Given the company's micro status and recent start date, liquidity appears adequate for current operations but should be monitored closely as the business scales.

4. Monitoring Points:

• Future annual accounts and cash flow statements to confirm revenue growth and profitability.
• Timely submission of statutory filings to avoid penalties and ensure transparency.
• Changes in working capital components, especially accruals and deferred income balances.
• Any increase in liabilities or use of external financing which could affect credit risk.
• Management's ability to scale operations and generate sustainable cash flow given the niche industry (medical instruments and health activities).
• Stability and conduct of directors, with no current disqualifications or concerns noted.